Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in ...

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics, as the Chinese biotech tacks on preclinical ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

A decades-old way to bridge buyers and sellers on price, contingent value rights have recently seen an uptick in use due to a ...

Nanobiotix (NBTX +3.54%) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering ...

Rhode Island continues its investment in its biotech sector, which state leaders are hoping will become a major economic ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

From top left, clockwise: Fred Hutch’s Hilary Hehman; Oregon Venture Fund’s Eric Rosenfeld; Alexandria’s Alice Ly; University of Washington’s François Baneyx; sp3nw’s Michaele Armstrong; and ...